rs11130254
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001243925.2(MAPKAPK3):c.*721A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0801 in 152,320 control chromosomes in the GnomAD database, including 682 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.080 ( 682 hom., cov: 34)
Exomes 𝑓: 0.059 ( 0 hom. )
Consequence
MAPKAPK3
NM_001243925.2 3_prime_UTR
NM_001243925.2 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.912
Publications
20 publications found
Genes affected
MAPKAPK3 (HGNC:6888): (MAPK activated protein kinase 3) This gene encodes a member of the Ser/Thr protein kinase family. This kinase functions as a mitogen-activated protein kinase (MAP kinase)- activated protein kinase. MAP kinases are also known as extracellular signal-regulated kinases (ERKs), act as an integration point for multiple biochemical signals. This kinase was shown to be activated by growth inducers and stress stimulation of cells. In vitro studies demonstrated that ERK, p38 MAP kinase and Jun N-terminal kinase were all able to phosphorylate and activate this kinase, which suggested the role of this kinase as an integrative element of signaling in both mitogen and stress responses. This kinase was reported to interact with, phosphorylate and repress the activity of E47, which is a basic helix-loop-helix transcription factor known to be involved in the regulation of tissue-specific gene expression and cell differentiation. Alternate splicing results in multiple transcript variants that encode the same protein. [provided by RefSeq, Sep 2011]
MAPKAPK3 Gene-Disease associations (from GenCC):
- patterned macular dystrophy 3Inheritance: AD, Unknown Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MAPKAPK3 | NM_001243925.2 | c.*721A>C | 3_prime_UTR_variant | Exon 11 of 11 | ENST00000621469.5 | NP_001230854.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MAPKAPK3 | ENST00000621469.5 | c.*721A>C | 3_prime_UTR_variant | Exon 11 of 11 | 1 | NM_001243925.2 | ENSP00000478922.1 | |||
| MAPKAPK3 | ENST00000357955.6 | c.*721A>C | 3_prime_UTR_variant | Exon 11 of 11 | 1 | ENSP00000350639.2 | ||||
| MAPKAPK3 | ENST00000446044.5 | c.*721A>C | 3_prime_UTR_variant | Exon 13 of 13 | 1 | ENSP00000396467.1 | ||||
| MAPKAPK3 | ENST00000451680.1 | c.*721A>C | downstream_gene_variant | 2 | ENSP00000394894.1 |
Frequencies
GnomAD3 genomes AF: 0.0802 AC: 12200AN: 152168Hom.: 682 Cov.: 34 show subpopulations
GnomAD3 genomes
AF:
AC:
12200
AN:
152168
Hom.:
Cov.:
34
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0588 AC: 2AN: 34Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 24 show subpopulations
GnomAD4 exome
AF:
AC:
2
AN:
34
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
24
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
0
AN:
6
Middle Eastern (MID)
AF:
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
AC:
1
AN:
20
Other (OTH)
AF:
AC:
1
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0801 AC: 12201AN: 152286Hom.: 682 Cov.: 34 AF XY: 0.0797 AC XY: 5934AN XY: 74454 show subpopulations
GnomAD4 genome
AF:
AC:
12201
AN:
152286
Hom.:
Cov.:
34
AF XY:
AC XY:
5934
AN XY:
74454
show subpopulations
African (AFR)
AF:
AC:
960
AN:
41582
American (AMR)
AF:
AC:
1082
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
AC:
134
AN:
3468
East Asian (EAS)
AF:
AC:
3
AN:
5182
South Asian (SAS)
AF:
AC:
71
AN:
4820
European-Finnish (FIN)
AF:
AC:
1408
AN:
10606
Middle Eastern (MID)
AF:
AC:
19
AN:
294
European-Non Finnish (NFE)
AF:
AC:
8243
AN:
68012
Other (OTH)
AF:
AC:
156
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
600
1200
1800
2400
3000
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
136
272
408
544
680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
43
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.